- Home
- CDNA vs JFR Comparison
CDNA vs JFR Comparison
Compare CDNA & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- JFR
- Stock Information
- Founded
- CDNA 1998
- JFR 2004
- Country
- CDNA United States
- JFR United States
- Employees
- CDNA N/A
- JFR N/A
- Industry
- CDNA Medical Specialities
- JFR Trusts Except Educational Religious and Charitable
- Sector
- CDNA Health Care
- JFR Finance
- Exchange
- CDNA Nasdaq
- JFR Nasdaq
- Market Cap
- CDNA 1.1B
- JFR 1.2B
- IPO Year
- CDNA 2014
- JFR N/A
- Fundamental
- Price
- CDNA $21.44
- JFR $8.66
- Analyst Decision
- CDNA Buy
- JFR
- Analyst Count
- CDNA 8
- JFR 0
- Target Price
- CDNA $26.43
- JFR N/A
- AVG Volume (30 Days)
- CDNA 851.0K
- JFR 621.7K
- Earning Date
- CDNA 02-26-2025
- JFR 01-01-0001
- Dividend Yield
- CDNA N/A
- JFR 11.31%
- EPS Growth
- CDNA N/A
- JFR N/A
- EPS
- CDNA N/A
- JFR N/A
- Revenue
- CDNA $312,775,000.00
- JFR N/A
- Revenue This Year
- CDNA $19.85
- JFR N/A
- Revenue Next Year
- CDNA $11.34
- JFR N/A
- P/E Ratio
- CDNA N/A
- JFR N/A
- Revenue Growth
- CDNA 5.26
- JFR N/A
- 52 Week Low
- CDNA $7.42
- JFR $7.61
- 52 Week High
- CDNA $34.84
- JFR $8.82
- Technical
- Relative Strength Index (RSI)
- CDNA 43.79
- JFR 33.65
- Support Level
- CDNA $21.09
- JFR $8.89
- Resistance Level
- CDNA $25.95
- JFR $9.08
- Average True Range (ATR)
- CDNA 1.61
- JFR 0.10
- MACD
- CDNA 0.02
- JFR -0.04
- Stochastic Oscillator
- CDNA 19.46
- JFR 12.50
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.